Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial

Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial

Abstract This phase Ib study compared the effects of AZD9977, a selective mineralocorticoid receptor modulator with predicted low hyperkalemia risk, with spironolactone on serum potassium (sK+) in patients with heart failure (HF) with preserved or mildly reduced ejection fraction (EF; ≥40%), and ren...

Full description

Saved in:
Bibliographic Details
Main Authors: Iain B. Squire (Author), Anders Gabrielsen (Author), Peter J. Greasley (Author), Linda Wernevik (Author), Judith Hartleib‐Geschwindner (Author), Julie Holden (Author), Susanne Johansson (Author), Anna Rudvik (Author), José Sánchez (Author), Krister Bamberg (Author), Johanna Melin (Author), Andrew Whittaker (Author)
Format: Book
Published: Wiley, 2022-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items